Indemnification Agreements between Myriad Genetics, Inc. and Directors and Executive Officers
Myriad Genetics, Inc. has entered into standard indemnification agreements with its directors and executive officers. These agreements protect the individuals from certain legal liabilities that may arise from their roles at the company. The listed directors and officers each signed the agreement on the specified dates. The agreements are intended to provide legal protection and support for these individuals while they serve in their official capacities.
Exhibit 10.2
Attachment
Each of the following directors and executive officers of Myriad Genetics, Inc. has entered into the Company’s standard form Indemnification Agreement.
| Directors and Executive Officer | Execution Date |
| John T. Henderson, M.D., Chairman of the Board | June 02, 2009 |
| Walter Gilbert, Ph.D., Vice Chairman of the Board | June 02, 2009 |
| Lawrence C. Best, Director | September 16, 2009 |
| Heiner Dreismann, Ph.D., Director | September 16, 2010 |
| Dennis H. Langer, M.D., J.D., Director | June 02, 2009 |
| S. Louise Phanstiel, Director | September 16, 2009 |
| Mark C. Capone, President and Chief Executive Officer | June 16, 2009 |
| Alexander Ford, President, Myriad Genetic Laboratories, Inc. | July 01, 2015 |
| Gary A. King, EVP International Operations | June 13, 2013 |
| Jerry S. Lanchbury, Ph.D., Chief Scientific Officer | June 16, 2009 |
| Richard M. Marsh, Esq., EVP, General Counsel and Secretary | June 16, 2009 |
| Ralph L. McDade, President, Myriad RBM, Inc. | June 05, 2014 |
| R. Bryan Riggsbee, Chief Financial Officer and Treasurer | February 23, 2015 |
| Bernard F. Tobin, President, Crescendo Biosciences, Inc. | February 23, 2015 |
| Mark Verratti, President, Assurex Health, Inc. | September 19, 2017 |
